Outcome of twin pregnancy in a renal transplant recipient treated with tacrolimus

Transplantation

Volumn 67, Issue 3, 1999, Pages 490-492

  Vyas, Shefali ^a   Kumar, Alok ^a   Piecuch, Steven ^a   Hidalgo, Guillermo ^a   Singh, Anup ^a   Anderson, Virginia ^a   Markell, Mariana S ^a   Baqi, Noosha ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE AGENT; MILRINONE; TACROLIMUS;

ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CASE REPORT; CONGESTIVE HEART FAILURE; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MUSCLE ATROPHY; NEWBORN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; THROMBOSIS; TWIN PREGNANCY;

EID: 0033557292     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199902150-00028     Document Type: Article

References (16)

1. Hooks M. Tacrolimus, a new immunosuppressant: a review of literature. Ann Pharmacol 1994; 28: 510.
2. Tanaka H, Nakahara K, Hatanaka H, Inamura N, Kuroda A. Discovery and development of a novel immunosuppressant, tacrolimus hydrate. Yakugaku Zasshi 1997; 117 (8): 542.
3. Radomski JS, Ahlswede BA, Jarrell BE, et al. Outcomes of 500 pregnancies in 335 female kidney, liver and heart transplant recipients. Transplant Proc 1995; 27 (1): 1089.
4. Jain A, Venkatramanan R, Fung J, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997; 64: 559.
5. Davison JM, Milne JE. Pregnancy and renal transplantation. Br J Urol 1997; 80 (Suppl1): 29.
6. Midtvedt K, Hartmann A, Brekke I, Lyngdal P, Bentdal O, Haugen G. Successful pregnancies in a combined pancreas and renal allograft recipient and in a renal graft recipient on tacrolimus treatment. Nephrol Dialysis Transplant 1997; 12: 2764.
7. Resch B, Mache CJ, Windhager T, Holzer H, Leitner G, Muller W. FK 506 and successful pregnancy in a patient after renal transplantation. Transplant Proc 1998; 30 (1): 163.
8. Yoshimura N, Oka T, Fujiwara Y, Yasumura T, Honjo H. A case report of pregnancy in renal transplant recipient treated with FK506 (tacrolimus). Transplantation 1996; 61 (10): 1552.
9. Matitiau A, Perez-Atayde A, Sanders SP, et al. Infantile dilated cardiomyopathy: relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 1994; 90 (3): 1310.
10. Collier D St J, Calne R, Thiru S, et al. FK-506 in experimental renal allografts. Transplant Proc 1987; 5: 3975.
11. Nomoto S, Fujiwara H, Ban T, Ohara K. Cardiotoxicity of long term intravenous administration of FK-506 in rabbits: dose relationship and recovery after discontinuance. Transplant Proc 1994; 26: 855.
12. Baruch Y, Weitzman E, Markiewiex W, Eisenman A, Eid A, Enat R. Anasarc and hypertrophic cardiomyopathy in a liver transplant patient on FK506 relieved after a switch to Neoral. Transplant Proc 1996; 28: 2250.
13. Atkinson P, Joubert G, Grant D, et al. Hypertrophic cardiomyopathy associated with tacrolimus in pediatric transplant patients. Lancet 1995; 345: 894.
14. Atkinson P, Joubert GI, Guiraudon C, et al.. Arteritis and increased intracellular calcium as a possible mechanism for tacrolimus-related cardiac toxicity in a pediatric transplant recipient. Transplantation 1997; 64: 773.
15. Shipley JB, Tolman D, Hastillo A, Hess ML. Milrinone: basic and clinical pharmacology and acute and chronic management. Am J Med Sci 1996; 311: 286.
16. Lam E, Martin MM, Timmerman AP, et al. A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. J Biol Chem 1995; 270: 26511.